- Home
- NTRP vs PHIO Comparison
NTRP vs PHIO Comparison
Compare NTRP & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- PHIO
- Stock Information
- Founded
- NTRP 1985
- PHIO 2011
- Country
- NTRP United States
- PHIO United States
- Employees
- NTRP N/A
- PHIO N/A
- Industry
- NTRP
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- PHIO Health Care
- Exchange
- NTRP NYSE
- PHIO Nasdaq
- Market Cap
- NTRP 2.3M
- PHIO 2.3M
- IPO Year
- NTRP N/A
- PHIO N/A
- Fundamental
- Price
- NTRP $1.76
- PHIO $2.47
- Analyst Decision
- NTRP
- PHIO Strong Buy
- Analyst Count
- NTRP 0
- PHIO 1
- Target Price
- NTRP N/A
- PHIO $36.00
- AVG Volume (30 Days)
- NTRP 32.9K
- PHIO 52.9K
- Earning Date
- NTRP 12-03-2024
- PHIO 11-14-2024
- Dividend Yield
- NTRP N/A
- PHIO N/A
- EPS Growth
- NTRP N/A
- PHIO N/A
- EPS
- NTRP N/A
- PHIO N/A
- Revenue
- NTRP $754,818.00
- PHIO N/A
- Revenue This Year
- NTRP $499.45
- PHIO N/A
- Revenue Next Year
- NTRP $363.49
- PHIO N/A
- P/E Ratio
- NTRP N/A
- PHIO N/A
- Revenue Growth
- NTRP 541.48
- PHIO N/A
- 52 Week Low
- NTRP $1.39
- PHIO $2.17
- 52 Week High
- NTRP $6.81
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- NTRP 44.53
- PHIO 42.71
- Support Level
- NTRP $1.51
- PHIO $2.17
- Resistance Level
- NTRP $1.95
- PHIO $2.66
- Average True Range (ATR)
- NTRP 0.18
- PHIO 0.30
- MACD
- NTRP 0.02
- PHIO -0.03
- Stochastic Oscillator
- NTRP 64.10
- PHIO 19.71
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.